September 8, 2022
Profiling E3 ligase compounds and the Implications in Drug Discovery
By: Abdul Haseeb, Ph.D. Drugging the Undruggable Tremendous progress in genomics, transcriptomics and proteomics…
September 1, 2022
Accelerating PROTAC drug discovery: Establishing a Relationship Between Ubiquitination and Target Protein Degradation
MALVERN, Pa., SEP 1, 2022 – LifeSensors Inc., a Biotech and Drug Discovery Company focused…
February 2, 2022
PROTAC Drug Discovery January 2022 Webinar
PROTAC Drug Discovery Webinar January 2022
August 12, 2021
The Power of PROTACs
By: Rebekah Varghese, Derrick Padykula, & Jacob Huang All the FDA-approved drugs combined interact with…
July 22, 2021
Plunging into the Plight of Parkinson’s Disease
By: Rebekah Varghese and Derrick Padykula Parkinson’s Disease (PD) is the second most common neurodegenerative…
March 1, 2021
Ubiquitin-Proteasome System
The Ubiquitin-Proteasome System: An Overview The Ubiquitin-Proteasome system (UPS) is a highly complex, temporally…
November 23, 2020
The Biomarkers of Alzheimer’s Disease
November is a month dedicated to the awareness of Alzheimer’s Disease, an age-related illness of…
October 31, 2019
Autophagy
Autophagy Autophagy is a process by which eukaryotic cells degrade and recycle proteins and organelles…
October 31, 2019
Ubiquitin and Neuroscience
Ubiquitin and Neuroscience Neurodegenerative diseases are often characterized by excessive or dysfunctional proteins and protein…
May 17, 2019
Lewy Body Dementia – Hiding in Plain Sight
Lewy Body Dementia (LBD) is a debilitating neurodegenerative disease that is increasingly becoming a public…
August 10, 2018
PARKINSON’S DISEASE: BIOMARKERS OF EARLY DISCOVERY
By: Mark Tingey, Katelyn Roberts, and Meredith Paterson Parkinson’s disease is often referred to as…